Half Year Results 

Dechra's profits take a hit

Dechra's profits take a hit

Dechra (DHP) continued its expansion in the North American pet health market during the first-half of FY2019, hiring more sales representatives to make more one-to-one contact with veterinarians. That, together with the temporary absence of a market competitor to the animal medicine specialist’s endocrinology product, helped boost revenue across North America by almost a fifth at constant exchange rates.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now